U.S. Markets closed

Amgen Earnings, Revenue Beat in Q1

Investing.com - Amgen (NASDAQ:AMGN) reported first quarter earnings that Beat analysts' expectations on Tuesday and revenue that topped forecasts.

The firm reported earnings per share of $3.56 on revenue of $5.56B. Analysts polled by Investing.com expected EPS of $3.48 on revenue of $5.53B. That compared to EPS of $3.47 on revenue of $5.55B in the same period a year earlier. The company had reported EPS of $3.42 on revenue of $6.23B in the previous quarter.

Amgen shares lost 0.18% to trade at $179.00 in after-hours trade following the report.

Amgen follows other major Healthcare sector earnings this month


On April 16, J&J reported first quarter EPS of $2.1 on revenue of $20.02B, compared to forecasts of EPS of $2.04 on revenue of $19.61B.

Pfizer earnings Beat analysts' expectations on Tuesday, with first quarter EPS of $0.85 on revenue of $13.12B. Investing.com analysts expected EPS of $0.75 on revenue of $13B

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Related Articles

Apple optimistic on sales as iPhone price cuts help in China

Stocks - Alphabet and Apple Hold Techs Back; Stocks End Mixed

Verisk Earnings inline, Revenue Beats In Q1